Overview

Gender

male

Eric E. Hedrick, M.D.has served as our Chief Medical Officer since May 2012.

Prior to joining Epizyme®, Dr. Hedrick served as Vice President, Oncology Development, at Pharmacyclics, Inc., a biopharmaceutical company, from August 2010 to April 2012, and Interim Chief Medical Officer from May 2011 to April 2012. From October 2009 to August 2010, Dr. Hedrick was an independent drug development consultant for Pharmacyclics and other companies.

From November 2000 to September 2009, Dr. Hedrick held a variety of positions at Genentech, Inc., a biotechnology company, including Medical Director, Group Medical Director and clinical scientist. Prior to his time at Genentech, Dr. Hedrick was an Associate Attending Physician at Memorial Sloan-Kettering Cancer Center, where he focused on clinical research in non-Hodgkin lymphoma, myelodysplastic syndromes, multiple myeloma and hematopoietic growth factors.

He is a board-certified medical oncologist, formerly a fellow and staff physician on the Hematology Service at Memorial Sloan Kettering Cancer Center.

Dr. Hedrick received a B.A. in biology from Boston University and an M.D. from the University of Maryland.